TNF-RI, Recombinant, Human, Soluble (Tumor Necrosis Factor Receptor Superfamily Member 1A, Tumor Necrosis Factor Receptor 1, Tumor Necrosis Factor Receptor Type I, TNFR-I, p60, p55, CD120a, TNFRSF1A, TNFAR, TNFR1, FPF, TBP1, TNF-R, p55-R, TNFR55, TNFR60, TNF-R-I, TNF-R55, MGC19588)

Catalog No : USB-220340
466.68€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name TNF-RI, Recombinant, Human, Soluble (Tumor Necrosis Factor Receptor Superfamily Member 1A, Tumor Necrosis Factor Receptor 1, Tumor Necrosis Factor Receptor Type I, TNFR-I, p60, p55, CD120a, TNFRSF1A, TNFAR, TNFR1, FPF, TBP1, TNF-R, p55-R, TNFR55, TNFR60, TNF-R-I, TNF-R55, MGC19588)
Catalog No USB-220340
Supplier’s Catalog No 220340
Supplier US Biologicals
Source antigen Recombinant, E. coli
Reactivity
Cross reactivity
Applications
Molecular weight 18.3
Storage -20°C
Other names
Grade Highly Purified
Purity ~98% (SDS-PAGE, HPLC)
Form Supplied as a lyophilized powder in 5mM Tris, pH 8.0. No preservative added. Reconstitute with sterile 5mM Tris, pH 8.0 to 1mg/ml.
Reactivity life 12 months
Note For reserch purpose only
Purity ~98% (SDS-PAGE, HPLC)
Description Tumor Necrosis Factor receptor type I (TNF-RI) is also referred as p60. The p60 form of the receptor is primarily expressed on epithelial cells. Recombinant human soluble TNF receptor Type I (sTNF-RI) contains 162aa residues comprising the extra cellular domain of TNF Receptor Type I. Source: Recombinant protein corresponding to soluble human TNF receptor Type I, expressed in E. coli. Molecular Weight: ~18.3kD Biological Activity: Determined by its inhibitory effect of the TNF-a mediated cytotoxicity in murine L-929 cells. The ED50 for the effect in the presence of 0.25ng/ml of recombinant TNF-a, is 0.05mg/ml. Endotoxin: <0.1ng/ug Storage and Stability: Lyophilized powder may be stored at -20°C. Reconstitute with sterile buffer. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.